MICHELE PARKHILL: Open Payments
NPI 1124335567 · SCHNECKSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,105 in 168 payments from 18 companies in 2025. Trend: 2023 $2,410 · 2024 $3,094 · 2025 $3,105
Food & beverage: $2,899Education: $206
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $689 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $334 |
| Regeneron Healthcare Solutions, Inc. | 8 | $330 |
| Galderma Laboratories, L.P. | 21 | $306 |
| Janssen Biotech, Inc. | 7 | $287 |
| UCB, Inc. | 19 | $201 |
| Incyte Corporation | 14 | $163 |
| Organon LLC | 17 | $158 |
| Lilly USA, LLC | 7 | $135 |
| GENZYME CORPORATION | 4 | $117 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, NEMLUVIO, RINVOQ, Bimzelx, OPZELURA, Winlevi.
Industry payments across PA — which companies pay providers there.
